RecruitingNCT05231135
A Registry Study on HIV-related Lymphoma
Studying OBSOLETE: HIV-related Non-Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rotkreuzklinikum München gGmbH
- Principal Investigator
- Marcus Hentrich, MDRotkreuzklinikum München
- Enrollment
- 300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2029
Study locations (6)
- Red Cross Hospital Munich, Munich, Select One Option, Germany
- University Hospital Cologne, Cologne, Germany
- Amsterdam University Medical Centers, Amsterdam, Netherlands
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Hospital Universitario de Salamanca, Salamanca, Spain
- University Hospital of Wales, Cardiff, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05231135 on ClinicalTrials.govOther trials for OBSOLETE: HIV-related Non-Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: HIV-related Non-Hodgkin lymphoma →